US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DEFIANCE DAILY TARGET 2X LONG HIMS ETF

27.52

+1.827.08%

Pre-market: 27.38-0.1400-0.51%05:00 EDT

Volume:407.30K

Turnover:11.58M

Market Cap:56.13M

PE:- -

High:29.75

Open:26.41

Low:26.30

Close:25.70

52wk High:391.58

52wk Low:12.38

Shares:2.04M

Float Shares:2.04M

Volume Ratio:1.57

T/O Rate:19.97%

Dividend:1.98

Dividend Rate:7.19%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hims & Hers Health is Maintained at Neutral by Citigroup

FDA Advisers Back First Four of Seven Unapproved Peptides Under Review for Looser Rules

Why Is Hims & Hers Health Stock Surging on Thursday?

Hims Gains After FDA Panel Votes to Place Popularly Used Peptide Bpc-157 on Compounding List

Hims & Hers Health Shares up 10% After FDA Advisory Panel Votes to Place Bpc-157 Peptide on Allowed Pharmacy Compounding List

THOMSON REUTERS

Hims & Hers Shares up 2% After Telehealth Firm Urged FDA to Broaden Access to Some Peptides in Panel Meeting

THOMSON REUTERS

Peptides Could Soon Become Widely Available in the U.S. Here's What Happens Next.

Hims & Hers Health Inc : Citigroup Raises Target Price to $35 from $28

THOMSON REUTERS

Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares Valued at $229,075.99

Trump's FDA May Soon Back Peptides. Should You Buy In?

Hims & Hers Accounting Chief Exits

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

THOMSON REUTERS

Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 9.35%

Press Release: Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

Hims & Hers Sets Second-quarter Results Release and Investor Call

Hims & Hers's Peptide Opportunity Remains in Focus

Hims & Hers Health is Maintained at Neutral by B of a Securities

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)

Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56

Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/HIMZ/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HIMZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","market":"US","secType":"STK","nameCN":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF","latestPrice":27.52,"timestamp":1790798400000,"preClose":25.7,"halted":0,"volume":407302,"hourTrading":{"tag":"盘前","latestPrice":27.38,"preClose":27.52,"latestTime":"05:00 EDT","volume":690,"amount":19472.4003,"timestamp":1790845224577,"change":-0.14,"changeRate":-0.005087,"amplitude":0.028706},"delay":0,"changeRate":0.0708171206225681,"floatShares":2039610,"shares":2039610,"eps":0,"marketStatus":"Pre-Mkt","change":1.82,"latestTime":"10-01 05:41:15 EDT","open":26.41,"high":29.75,"low":26.3,"amount":11584801.17956,"amplitude":0.134241,"askPrice":27.91,"askSize":385,"bidPrice":27.61,"bidSize":385,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":27.52,"sharesOutstanding":57385000,"nav":25.66,"aum":52079715.62,"dividendRate":0.071948,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":27.38,"preClose":27.52,"latestTime":"05:00 EDT","volume":690,"amount":19472.4003,"timestamp":1790845224577,"change":-0.14,"changeRate":-0.005087,"amplitude":0.028706},"postHourTrading":{"tag":"盘后","latestPrice":27.9046,"preClose":27.52,"latestTime":"19:54 EDT","volume":3095,"amount":85693.15,"timestamp":1790812484549,"change":0.3846,"changeRate":0.013975,"amplitude":0.014702},"volumeRatio":1.5673828957191933,"impliedVol":1.4339,"impliedVolPercentile":0.336},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","floatShares":2039610,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.5673828957191933,"shares":2039610,"dividePrice":1.98,"high":29.75,"amplitude":0.134241,"preClose":25.7,"low":26.3,"week52Low":12.3816,"pbRate":"--","week52High":391.58,"institutionHeld":0,"latestPrice":27.52,"eps":0,"divideRate":0.071948,"volume":407302,"delay":0,"ttmEps":0,"open":26.41,"prevYearClose":81.06,"prevWeekClose":27.08,"prevMonthClose":27.52,"prevQuarterClose":27.52,"fiveDayClose":25.38,"twentyDayClose":26.2525,"sixtyDayClose":52.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIMZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-19","symbol":"HIMZ","defaultRemindTime":1773927000000,"type":"split","dateTimestamp":1773892800000,"forFactor":14,"toFactor":1,"ratio":14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIMZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIMZ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIMZ\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653778588","title":"Hims & Hers Health is Maintained at Neutral by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2653778588","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653778588?lang=en_us&edition=fundamental","pubTime":"2026-07-24 03:16","pubTimestamp":1784834160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings(END) Dow Jones NewswiresJuly 23, 2026 15:16 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMS","HIYY","HMYY","HEAL","THNR","GLAM","HIMY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653720966","title":"FDA Advisers Back First Four of Seven Unapproved Peptides Under Review for Looser Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2653720966","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653720966?lang=en_us&edition=fundamental","pubTime":"2026-07-24 02:37","pubTimestamp":1784831846,"startTime":"0","endTime":"0","summary":"\"Advisers backing broader access argued that patients face safety risks when obtaining these products from the unregulated or gray market.On the other hand, those who voted against were doctors and patient representatives.\"I'm concerned that we're responding to a market-induced demand rather than a decision","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nL1N43P120:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","BK4196","GLAM","HIYY","HIMZ","HIMS","HMYY","HEAL","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653771213","title":"Why Is Hims & Hers Health Stock Surging on Thursday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2653771213","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653771213?lang=en_us&edition=fundamental","pubTime":"2026-07-24 02:34","pubTimestamp":1784831640,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc (NYSE: HIMS) stock surges Thursday after an FDA advisory committee votes on adding BPC-157 to the allowed pharmacy compounding list.","market":"hk","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=3840,format=auto,quality=85/files/images/story/2026/07/23/Hims--Hers-Health-Inc.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=3840,format=auto,quality=85/files/images/story/2026/07/23/Hims--Hers-Health-Inc.jpg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/07/60651683/why-is-hims-hers-health-stock-surging-on-thursday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/07/60651683/why-is-hims-hers-health-stock-surging-on-thursday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["HIMS","HMYY","THNR","GLAM","HIYY","HEAL","HIMY","BK4196","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653229257","title":"Hims Gains After FDA Panel Votes to Place Popularly Used Peptide Bpc-157 on Compounding List","url":"https://stock-news.laohu8.com/highlight/detail?id=2653229257","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653229257?lang=en_us&edition=fundamental","pubTime":"2026-07-24 01:09","pubTimestamp":1784826558,"startTime":"0","endTime":"0","summary":"BUZZ-Hims gains after FDA panel votes to place popularly used peptide BPC-157 on compounding list** Shares of telehealth firm Hims & HersHIMS.Nrise 11.4% to $35.29** A panel of advisers to the U.S. Food and Drug Administration on Thursday voted to place a widely used peptide called BPC-157 on a list that would allow broader pharmacy compounding** Himsis setto tap what analysts estimate could be a multi-billion-dollar market for peptides if U.S. regulators loosen manufacturing restrictions** Chief Medical Officer Anant Vinjamoori tellspanelHims stands to benefit commercially if BPC-157 were added to the 503A list** We think longer still before it could become a meaningful contributor to HIMS, as the company has expressed that it does not necessarily want to rush to be first to market, says brokerage Leerink** Brokerage adds  outcome is a positive catalyst for the stock as BPC-157 is likely one of the more commercially viable of the sevenpeptidesfor a broad audience.** HIMS up 6% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nL4N43P27K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HEAL","HIMS","THNR","HIYY","HIMZ","HIMY","BK4196","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653223137","title":"Hims & Hers Health Shares up 10% After FDA Advisory Panel Votes to Place Bpc-157 Peptide on Allowed Pharmacy Compounding List","url":"https://stock-news.laohu8.com/highlight/detail?id=2653223137","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653223137?lang=en_us&edition=fundamental","pubTime":"2026-07-24 00:50","pubTimestamp":1784825421,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nFWN43P176:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HMYY","HIMZ","HIYY","HEAL","HIMS","BK4196","HIMY","THNR","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653049726","title":"Hims & Hers Shares up 2% After Telehealth Firm Urged FDA to Broaden Access to Some Peptides in Panel Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2653049726","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653049726?lang=en_us&edition=fundamental","pubTime":"2026-07-23 22:31","pubTimestamp":1784817111,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nFWN43P0OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","GLAM","HMYY","HEAL","HIMZ","HIMY","HIYY","THNR","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653723484","title":"Peptides Could Soon Become Widely Available in the U.S. Here's What Happens Next.","url":"https://stock-news.laohu8.com/highlight/detail?id=2653723484","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653723484?lang=en_us&edition=fundamental","pubTime":"2026-07-23 21:18","pubTimestamp":1784812680,"startTime":"0","endTime":"0","summary":"If the FDA allows these seven peptides to be reclassified, that means compounding pharmacies can legally produce themA group of independent advisers to the FDA is meeting Thursday and Friday to vote w","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIMZ","GLAM","HEAL","BK4196","THNR","HIMS","HMYY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653499177","title":"Hims & Hers Health Inc : Citigroup Raises Target Price to $35 from $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2653499177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653499177?lang=en_us&edition=fundamental","pubTime":"2026-07-23 18:34","pubTimestamp":1784802859,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nFWN43P0LP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMS","HEAL","HIMZ","HIYY","GLAM","HIMY","HMYY","THNR","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653245241","title":"Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares Valued at $229,075.99","url":"https://stock-news.laohu8.com/highlight/detail?id=2653245241","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653245241?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:31","pubTimestamp":1784579494,"startTime":"0","endTime":"0","summary":"Hims & Hers CFO Oluyemi Okupe disposes of 7,163 common shares valued at $229,075.99Hims & Hers Health CFO Oluyemi Okupe exercised stock options for 7,163 Class A shares at USD 5.01 on July 17.Okupe so","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL767cfJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares Valued at $229,075.99","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIYY","HIMY","HEAL","THNR","BK4196","HIMS","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652823653","title":"Trump's FDA May Soon Back Peptides. Should You Buy In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2652823653","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652823653?lang=en_us&edition=fundamental","pubTime":"2026-07-18 09:31","pubTimestamp":1784338260,"startTime":"0","endTime":"0","summary":"The small-chain amino acids have picked up online fans, particularly in the workout and wellness worlds. One big backer: HHS Secretary Robert F. Kennedy Jr. Some on Wall Street see a potentially large","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HMYY","OZEM","NVO","LU1093756325.SGD","HIYY","BK4007","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVOX","BK4196","HIMS","HIMY","BK4585","BK4532","LU0154236417.USD","BK4588","LU1093756168.USD","NVOH","HEAL","BK4599","THNR","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652238849","title":"Hims & Hers Accounting Chief Exits","url":"https://stock-news.laohu8.com/highlight/detail?id=2652238849","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652238849?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:30","pubTimestamp":1784320200,"startTime":"0","endTime":"0","summary":"Hims & Hers Chief Accounting Officer Irene Becklund is departing the health and wellness platform effective Oct. 9, with CFO Yemi Okupe taking on interim CAO duties. Becklund joined in 2019 as the company's first Controller and is credited with building much of its financial reporting infrastructure. Her tenure spans several major corporate milestones, including Hims & Hers's IPO, strategic acquisitions, and international expansion. She'll serve as an adviser for several months to assist with the transition while the company searches for a permanent replacement.This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors. Dow Jones NewswiresJuly 17, 2026 16:30 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","HIMZ","HIMS","HIMY","THNR","BK4196","HEAL","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652128076","title":"Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2652128076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652128076?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:17","pubTimestamp":1784319420,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA3QRRTB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMS","BK4196","THNR","HEAL","HMYY","HIMZ","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652424679","title":"Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 9.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652424679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652424679?lang=en_us&edition=fundamental","pubTime":"2026-07-17 03:55","pubTimestamp":1784231711,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Hims and Hers Health (HIMS), with shares down $3.48 near $33.70. Options volume roughly in line with ave...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-hims-and-hers-health-with-shares-down-9-35-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-hims-and-hers-health-with-shares-down-9-35-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","HEAL","HMYY","HIMY","HIMS","HIMZ","HIYY","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651614124","title":"Press Release: Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651614124","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651614124?lang=en_us&edition=fundamental","pubTime":"2026-07-14 04:23","pubTimestamp":1783974180,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO--(BUSINESS WIRE)--July 13, 2026--Hims & Hers Health, Inc. (\"Hims & Hers\", NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2026 f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMS","HEAL","HIMY","HIYY","HMYY","HIMZ","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651419401","title":"Hims & Hers Sets Second-quarter Results Release and Investor Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2651419401","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651419401?lang=en_us&edition=fundamental","pubTime":"2026-07-14 04:05","pubTimestamp":1783973156,"startTime":"0","endTime":"0","summary":"Hims & Hers sets second-quarter results release and investor callHims & Hers schedules second-quarter 2026 results for Aug. 10, 2026.Conference call set for Aug. 10, 2026 at 5 p.m. ET, following the m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL8fblfc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIMZ","HEAL","BK4196","THNR","HIMS","HMYY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650755249","title":"Hims & Hers's Peptide Opportunity Remains in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2650755249","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650755249?lang=en_us&edition=fundamental","pubTime":"2026-07-10 00:14","pubTimestamp":1783613640,"startTime":"0","endTime":"0","summary":"1214 ET - Hims & Hers Health is likely to beat estimates and raise its full-year guidance when it reports second-quarter results, but its potential opportunity in peptides is the biggest thing on investors' minds, Truist Securities analysts say in a note. The analysts point to credit-card data from June, which shows strong trends in the telehealth company's GLP-1 business as the rest of its business remains stable, they say. However, the stock has gained lately due to enthusiasm around the company's potential in peptides, making for a tough risk-reward setup for shares heading into the Food and Drug Administration's advisory committee meeting later this month, which will consider several peptides, the analysts say. Even if the committee gives a favorable recommendation, Hims likely wouldn't see any meaningful revenue boost from a potential peptide offering before 2028, the analysts say.  Dow Jones NewswiresJuly 09, 2026 12:14 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HEAL","HMYY","HIMY","HIMS","HIMZ","HIYY","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650296659","title":"Hims & Hers Health is Maintained at Neutral by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2650296659","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650296659?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:38","pubTimestamp":1783597080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings(END) Dow Jones NewswiresJuly 09, 2026 07:38 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","HEAL","BK4196","HIYY","HIMZ","HIMY","HIMS","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650923855","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650923855","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650923855?lang=en_us&edition=fundamental","pubTime":"2026-07-09 17:50","pubTimestamp":1783590627,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS) and Tarsus Pharmaceutica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMS","HIMZ","TARS","HMYY","BK4196","BK4007","HIMY","THNR","HIYY","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649865930","title":"Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2649865930","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649865930?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:21","pubTimestamp":1783455682,"startTime":"0","endTime":"0","summary":"Hims & Hers CFO Oluyemi Okupe disposes of 7,163 common shares for $261,540.56Hims & Hers CFO Oluyemi Okupe sold 7,163 Class A shares at an average price of $36.49 on July 6, 2026.The sale followed the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL9VLQww:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMY","HIMZ","HIMS","HMYY","HEAL","THNR","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649690202","title":"Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649690202","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649690202?lang=en_us&edition=fundamental","pubTime":"2026-07-05 14:00","pubTimestamp":1783231200,"startTime":"0","endTime":"0","summary":"Many Americans would love a drug that makes them fitter, sharper, and more attractive. The peptides industry aims to oblige, and sales may soon be off to the races, courtesy of the Trump Administratio","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","NVOH","LU1093756325.SGD","OZEM","BK4532","IE00BKVL7J92.USD","HIYY","HIMY","IE00BZ1G4Q59.USD","BK4588","BK4585","HMYY","PPH","NVO","HEAL","HIMZ","LU1093756168.USD","NVOX","BK4007","THNR","BK4599","LU0154236417.USD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}